Australia Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Published : Aug-2017

No. of Pages : 133

order by fax Inquire before Buying request discount

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Neurology Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Neurology Devices Market, Australia 13
3.1 Neurology Devices Market, Australia, Revenue ($m), 2009-2016 13
3.2 Neurology Devices Market, Australia, Revenue ($m), 2016-2023 15
3.3 Neurology Devices Market, Australia, Volume (Units), 2009-2016 17
3.4 Neurology Devices Market, Australia, Volume (Units), 2016-2023 19
3.5 Neurology Devices Market, Australia, Company Share by Revenue ($m), 2016 21
4 CSF Management Market, Australia 23
4.1 CSF Management Market, Australia, Revenue Mix ($m), 2016 23
4.2 CSF Management Market, Australia, Segment Contribution (%), 2016 24
4.3 CSF Management Market, Australia, Revenue ($m), 2009-2016 25
4.4 CSF Management Market, Australia, Revenue ($m), 2016-2023 27
4.5 CSF Management Market, Australia, Volume (Units), 2009-2016 29
4.6 CSF Management Market, Australia, Volume (Units), 2016-2023 31
4.7 CSF Management Market, Australia, Distribution Share by Revenue ($m), 2015-2016 33
4.8 CSF Management Market, Australia, Company Share by Revenue ($m), 2016 34
5 Interventional Neurology Market, Australia 36
5.1 Interventional Neurology Market, Australia, Revenue Mix ($m), 2016 36
5.2 Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37
5.3 Interventional Neurology Market, Australia, Revenue ($m), 2009-2016 38
5.4 Interventional Neurology Market, Australia, Revenue ($m), 2016-2023 40
5.4.1 Embolization and Coiling Devices Market, Australia, Revenue ($m), by Segment, 2009-2016 42
5.4.2 Navigational System Market, Australia, Revenue ($m), by Segment, 2009-2016 44
5.4.3 Embolization and Coiling Devices Market, Australia, Revenue ($m), by Segment, 2016-2023 46
5.4.4 Navigational System Market, Australia, Revenue ($m), by Segment, 2016-2023 48
5.5 Interventional Neurology Market, Australia, Volume (Units), 2009-2016 50
5.6 Interventional Neurology Market, Australia, Volume (Units), 2016-2023 52
5.6.1 Embolization and Coiling Devices Market, Australia, Volume (Units), by Segment, 2009-2016 54
5.6.2 Navigational System Market, Australia, Volume (Units), by Segment, 2009-2016 56
5.6.3 Embolization and Coiling Devices Market, Australia, Volume (Units), by Segment, 2016-2023 58
5.6.4 Navigational System Market, Australia, Volume (Units), by Segment, 2016-2023 60
5.7 Interventional Neurology Market, Australia, Distribution Share by Revenue ($m), 2015-2016 62
5.8 Interventional Neurology Market, Australia, Company Share by Revenue ($m), 2016 63
6 Neurological Diagnostic Equipment Market, Australia 65
6.1 Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2016 65
6.2 Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66
6.3 Neurological Diagnostic Equipment Market, Australia, Revenue ($m), 2009-2016 67
6.4 Neurological Diagnostic Equipment Market, Australia, Revenue ($m), 2016-2023 69
6.5 Neurological Diagnostic Equipment Market, Australia, Volume (Units), 2009-2016 71
6.6 Neurological Diagnostic Equipment Market, Australia, Volume (Units), 2016-2023 73
6.7 Neurological Diagnostic Equipment Market, Australia, Distribution Share by Revenue ($m), 2015-2016 75
6.8 Neurological Diagnostic Equipment Market, Australia, Company Share by Revenue ($m), 2016 76
7 Neurostimulation Devices Market, Australia 78
7.1 Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2016 78
7.2 Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79
7.3 Neurostimulation Devices Market, Australia, Revenue ($m), 2009-2016 80
7.4 Neurostimulation Devices Market, Australia, Revenue ($m), 2016-2023 82
7.5 Neurostimulation Devices Market, Australia, Volume (Units), 2009-2016 84
7.6 Neurostimulation Devices Market, Australia, Volume (Units), 2016-2023 86
7.7 Neurostimulation Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 88
7.8 Neurostimulation Devices Market, Australia, Company Share by Revenue ($m), 2016 89
8 Neurosurgical Products Market, Australia 91
8.1 Neurosurgical Products Market, Australia, Revenue Mix ($m), 2016 91
8.2 Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92
8.3 Neurosurgical Products Market, Australia, Revenue ($m), 2009-2016 93
8.4 Neurosurgical Products Market, Australia, Revenue ($m), 2016-2023 95
8.5 Neurosurgical Products Market, Australia, Volume (Units), 2009-2016 97
8.6 Neurosurgical Products Market, Australia, Volume (Units), 2016-2023 99
8.7 Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), 2015-2016 101
8.8 Neurosurgical Products Market, Australia, Company Share by Revenue ($m), 2016 102
9 Radiosurgery Market, Australia 104
9.1 Radiosurgery Market, Australia, Revenue ($m), 2009-2016 104
9.2 Radiosurgery Market, Australia, Volume (Units), 2009-2016 106
9.3 Radiosurgery Market, Australia, Average Price ($), 2009-2016 108
10 Overview of Key Companies in Australia, Neurology Devices Market 109
10.1 Medtronic Plc 109
10.1.1 Company Overview 109
10.2 B. Braun Melsungen AG 109
10.2.1 Company Overview 109
10.3 Natus Medical Incorporated 109
10.3.1 Company Overview 109
10.4 Integra LifeSciences Holdings Corp 109
10.4.1 Company Overview 109
10.5 Stryker Corporation 110
10.5.1 Company Overview 110
10.6 DePuy Synthes Inc 110
10.6.1 Company Overview 110
10.7 Terumo Corp 110
10.7.1 Company Overview 110
10.8 Compumedics Ltd 110
10.8.1 Company Overview 110
10.9 St. Jude Medical LLC 111
10.9.1 Company Overview 111
10.10 Nihon Kohden Corp 111
10.10.1 Company Overview 111
10.11 LivaNova PLC 111
10.11.1 Company Overview 111
10.12 Boston Scientific Corp 111
10.12.1 Company Overview 111
11 Neurology Devices Market Pipeline Products 112
12 Financial Deals Landscape 116
12.1 Equity Offerings 116
12.1.1 Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares 116
12.1.2 Neurotech International Raises USD5.3 Million in IPO of Shares 117
12.2 Venture Financing 118
12.2.1 Saluda Medical Raises USD39.4 Million in Series D Financing 118
13 Recent Developments 119
13.1 Corporate Communications 119
13.1.1 May 24, 2017: Brain Resource appoints a financial services business leader as Director of Finance and Operations 119
13.1.2 May 23, 2017: Brain Resource appoints an experienced global digital business leader as Chief Executive Officer 119
13.1.3 Feb 22, 2017: Compumedics USA Management Strengthened to Deliver Core Business Growth 120
13.2 Financial Announcements 120
13.2.1 Feb 28, 2017: Compumedics Announces Financial Results For Half-Year Ended 31 December 2016 120
13.2.2 Jul 18, 2016: On track for increased sales and profits in FY16 Further growth expected in FY17 122
13.3 Government and Public Interest 122
13.3.1 Jun 15, 2017: Global Kinetics Big Data Highlights Unmet Needs & Global Variations in Parkinson's Disease 122
13.3.2 Jul 08, 2016: Computerised Cognitive Test Battery Matches Gold Standard for Hand Screening 123
13.4 Other Significant Developments 123
13.4.1 May 17, 2017: Compumedics: $3 Million In New Orders For China 123
13.4.2 May 17, 2017: Demand for Medibio's corporate wellness technology results in second commercial agreement with Australian Corporate Wellness provider 124
13.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 125
13.4.4 Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre 125
13.4.5 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 126
13.5 Product News 127
13.5.1 Jun 08, 2017: Independent researchers present first data validating Medibio's technology at the prestigious "Sleep 2017" 127
13.5.2 Aug 02, 2016: Study Provides New Insight into Relationship of Beta Amyloid and Apoe4 to Cognitive Decline 127
13.5.3 Jul 21, 2016: TGA Hazard Alert On Medtronic Neuromodulation Deep Brain Stimulation system pocket adaptors 128
14 Appendix 129
14.1 Research Methodology 130
14.1.1 Coverage 130
14.1.2 Secondary Research 130
14.1.3 Primary Research 131
14.1.4 Company Share Analysis 131
14.1.5 Distribution Share Analysis 131
14.1.6 Benchmarking 132
14.2 GlobalData Consulting 132
14.3 Contact Us 133
14.4 Disclaimer 133

1.1 List of Tables
Table 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 14
Table 2: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 16
Table 3: Neurology Devices Market, Australia, Volume (Units), Historic, 2009-2016 18
Table 4: Neurology Devices Market, Australia, Volume (Units), Forecast, 2016-2023 20
Table 5: Neurology Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 22
Table 6: CSF Management Market, Australia, Segment Contribution (%), 2016 24
Table 7: CSF Management Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 26
Table 8: CSF Management Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 28
Table 9: CSF Management Market, Australia, Volume (Units), Historic, 2009-2016 30
Table 10: CSF Management Market, Australia, Volume (Units), Forecast, 2016-2023 32
Table 11: CSF Management Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 33
Table 12: CSF Management Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 35
Table 13: Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37
Table 14: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 39
Table 15: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 41
Table 16: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43
Table 17: Navigational System Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 45
Table 18: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 47
Table 19: Navigational System Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 49
Table 20: Interventional Neurology Market, Australia, Volume (Units), Historic, 2009-2016 51
Table 21: Interventional Neurology Market, Australia, Volume (Units), Forecast, 2016-2023 53
Table 22: Embolization and Coiling Devices Market, Australia, Volume (Units), Historic, 2009-2016 55
Table 23: Navigational System Market, Australia, Volume (Units), Historic, 2009-2016 57
Table 24: Embolization and Coiling Devices Market, Australia, Volume (Units), Forecast, 2016-2023 59
Table 25: Navigational System Market, Australia, Volume (Units), Forecast, 2016-2023 61
Table 26: Interventional Neurology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 62
Table 27: Interventional Neurology Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 64
Table 28: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66
Table 29: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 68
Table 30: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 70
Table 31: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Historic, 2009-2016 72
Table 32: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Forecast, 2016-2023 74
Table 33: Neurological Diagnostic Equipment Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 75
Table 34: Neurological Diagnostic Equipment Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 77
Table 35: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79
Table 36: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 81
Table 37: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 83
Table 38: Neurostimulation Devices Market, Australia, Volume (Units), Historic, 2009-2016 85
Table 39: Neurostimulation Devices Market, Australia, Volume (Units), Forecast, 2016-2023 87
Table 40: Neurostimulation Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 88
Table 41: Neurostimulation Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 90
Table 42: Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92
Table 43: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 94
Table 44: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 96
Table 45: Neurosurgical Products Market, Australia, Volume (Units), Historic, 2009-2016 98
Table 46: Neurosurgical Products Market, Australia, Volume (Units), Forecast, 2016-2023 100
Table 47: Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 101
Table 48: Neurosurgical Products Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 103
Table 49: Radiosurgery Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 105
Table 50: Radiosurgery Market, Australia, Volume (Units), Historic, 2009-2016 107
Table 51: Radiosurgery Market, Australia, Average Price ($), Historic, 2009-2016 108
Table 52: Neurology Devices Market Pipeline Products 112
Table 53: Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares 116
Table 54: Neurotech International Raises USD5.3 Million in IPO of Shares 117
Table 55: Saluda Medical Raises USD39.4 Million in Series D Financing 118

1.2 List of Figures
Figure 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 13
Figure 2: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 15
Figure 3: Neurology Devices Market, Australia, Volume (Units), Historic, 2009-2016 17
Figure 4: Neurology Devices Market, Australia, Volume (Units), Forecast, 2016-2023 19
Figure 5: Neurology Devices Market, Australia, Company Share (%) 2016 21
Figure 6: CSF Management Market, Australia, Revenue Mix ($m), 2016 23
Figure 7: CSF Management Market, Australia, Segment Contribution (%), 2016 24
Figure 8: CSF Management Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 25
Figure 9: CSF Management Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 27
Figure 10: CSF Management Market, Australia, Volume (Units), Historic, 2009-2016 29
Figure 11: CSF Management Market, Australia, Volume (Units), Forecast, 2016-2023 31
Figure 12: CSF Management Market, Australia, Company Share (%) 2016 34
Figure 13: Interventional Neurology Market, Australia, Revenue Mix ($m), 2016 36
Figure 14: Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37
Figure 15: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 38
Figure 16: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 40
Figure 17: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 42
Figure 18: Navigational System Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44
Figure 19: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Figure 20: Navigational System Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 48
Figure 21: Interventional Neurology Market, Australia, Volume (Units), Historic, 2009-2016 50
Figure 22: Interventional Neurology Market, Australia, Volume (Units), Forecast, 2016-2023 52
Figure 23: Embolization and Coiling Devices Market, Australia, Volume (Units), Historic, 2009-2016 54
Figure 24: Navigational System Market, Australia, Volume (Units), Historic, 2009-2016 56
Figure 25: Embolization and Coiling Devices Market, Australia, Volume (Units), Forecast, 2016-2023 58
Figure 26: Navigational System Market, Australia, Volume (Units), Forecast, 2016-2023 60
Figure 27: Interventional Neurology Market, Australia, Company Share (%) 2016 63
Figure 28: Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2016 65
Figure 29: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66
Figure 30: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 67
Figure 31: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 69
Figure 32: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Historic, 2009-2016 71
Figure 33: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Forecast, 2016-2023 73
Figure 34: Neurological Diagnostic Equipment Market, Australia, Company Share (%) 2016 76
Figure 35: Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2016 78
Figure 36: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79
Figure 37: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 80
Figure 38: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 82
Figure 39: Neurostimulation Devices Market, Australia, Volume (Units), Historic, 2009-2016 84
Figure 40: Neurostimulation Devices Market, Australia, Volume (Units), Forecast, 2016-2023 86
Figure 41: Neurostimulation Devices Market, Australia, Company Share (%) 2016 89
Figure 42: Neurosurgical Products Market, Australia, Revenue Mix ($m), 2016 91
Figure 43: Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92
Figure 44: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 93
Figure 45: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 95
Figure 46: Neurosurgical Products Market, Australia, Volume (Units), Historic, 2009-2016 97
Figure 47: Neurosurgical Products Market, Australia, Volume (Units), Forecast, 2016-2023 99
Figure 48: Neurosurgical Products Market, Australia, Company Share (%) 2016 102
Figure 49: Radiosurgery Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 104
Figure 50: Radiosurgery Market, Australia, Volume (Units), Historic, 2009-2016 106

Filed in: Medical Device, Orthopedic Devices

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Australia Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027